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POD4
INCIDENCE AND PREVENTION OF NEEDLE
STICK INJURY RELATED TO SUBCUTANEOUS
INJECTION: EXAMPLE OF THE IMPACT OF A
LOW MOLECULAR WEIGHT HEPARIN SAFETY
SYRINGE
Bouvet E1, Lolom I1, Lamontagne F1, Gabriel S2,
Guilhaume C2
1GERES (Groupe d’Etude sur le Risque d’Exposition 
des Soignants aux agents infectieux) Paris, France;
2Sanoﬁ-Synthelabo, Bagneux, France
While several invasive procedures have been identiﬁed as
high-risk for blood-borne pathogens contamination, the
risk of Needle Stick Injury (NSI) related to subcutaneous
needles (SCN) is still underestimated. Nevertheless, NSI
after subcutaneous injections (SCI) must be considered as
important as they can be an indication for post-exposure
prophylaxis (PEP) for HIV prevention and durable follow
up in injured health care workers (HCW) resulting 
in ﬁnancial consequences. OBJECTIVE: Evaluate the
impact of the introduction of a safety syringe for SCI of
Low Molecular Weight Heparin (LMWH). METHODS:
A prospective multicenter study was conducted in 32 
hospitals throughout France from April 1, 1999 to March
3, 2000. All exposures to blood in 1506 voluntary nurses
working in medical and intensive care units were actively
notiﬁed using a standardised questionnaire (GERES).
Total number of invasive procedures was measured on a
weekly basis. The number of HCW participating and the
number of devices purchased were recorded as denomi-
nators during the survey period. RESULTS: 184 blood
exposures were reported during the study period. Among
the 130 NSI, 17 were related to SCI (15%). Six out of 7
were due to LMWH injections. All of these occurred with
non-safety syringes. The rate of NSI was 5 for 90,528
ordered LMWH non-safety syringes and 0 for 46,911
safety syringes. One of these NSI occurred with an HCV-
infected patient. CONCLUSIONS: NSI related to SCI are
relatively frequent in nurses with the extensive use of
drugs injected subcutaneously. Despite a low risk of viral
contamination through such injuries, such NSI may lead
to HIV and HCV follow up, and in some cases PEP. The
use of appropriate safety LMWH syringes may help to
reduce clinical and economic consequences of these
injuries.
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EVALUATION OF A PALLIATIVE CARE TEAM ON
RESOURCE UTILIZATION IN AN ACUTE CARE
SETTING
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As the elderly population grows, it becomes increasingly
important for the medical community to improve the
dying process and avoid the prolongation of death.
OBJECTIVES: Our network palliative care team (PCT)
assessed differences among patients who received their
services and those who did not. While multiple types of
intervention data were collected, this paper will focus on
(1) avoiding or withdrawing intubation and (2) prevent-
ing transfer to a higher level of care. METHODS: From
January 2001 through March 2002, data were collected
on 300 patients who met criteria for end-of-life using
National Hospice Guidelines. Of these patients, the PCT
received physician orders for their services on 111
patients, leaving 189 patients as the comparison group.
RESULTS: Among the 111 patients in the palliative care
program, 27 (24%) were intubated, compared with 105
(55%) of the 189 in the comparison group. Comparisons
of levels of care were also conducted. Among patients
with PCT services, the average length of hospital stay was
12.8 days (S.D. 14.8 days) compared with 14.3 days (S.D.
= 17.7 days) in the comparison group. For the interven-
tion group, about 7.0 days (55%) were spent in lower
level ﬂoor bed care, about 1.7 days (13%) in intermedi-
ate care (IMC), and 4.1 days (32%) in the highest level
of care—the intensive care unit (ICU). The comparison
group spent about 5.6 days (39%) in ﬂoor bed care, 2.3
days (16%) in IMC and 6.4 days (45%) in the ICU.
CONCLUSIONS: Palliative Care Team intervention was
associated with a lower proportion of patients under-
going intubation and a reduction in the percent of hos-
pital days spent in the intensive care unit. Further research
on costs associated with these resources is ongoing.
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PROVIDER ORDER ENTRY—ASSOCIATED COST
SAVINGS
Schaefer MG, DeLattre ML
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OBJECTIVES: Tablet splitting is utilized as a method of
avoiding high costs associated with drug therapy. Our
healthcare system encourages tablet splitting of approved
medications by patients who are willing and physically
able. An analysis was performed to project annual 
cost savings following electronic implementation of an
approved tablet splitting guide. METHODS: A tablet
splitting guide was developed to identify appropriate high
cost medications for tablet splitting. Tablets with narrow
therapeutic range, formulations potentially compromised
by splitting, and those difﬁcult to split consistently were
excluded from the guide. Providers in our healthcare
system enter all medication orders electronically through
a computerized patient record system. The database was
programmed to default to tablet splitting for the medica-
tions and dosages speciﬁed in the guide when selected by
the provider. For example, if simvastatin 40mg dose 
were selected, the computer would automatically select
the 80mg tablet and incorporate patient instructions to
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take one-half tablet. Staff was notiﬁed of the program-
ming change prior to execution, to ensure proper coun-
selling of patients. It was assumed that the rate of tablet
splitting would have remained unchanged without the
electronic implementation. Therefore, cost savings for
each medication and dose was calculated by multiplying
the absolute number of prescriptions by the percent
increase in tablet splitting realized. Difference in cost per
year between utilizing whole and half tablets was applied
to the additional number of prescriptions tablet split.
RESULTS: Analysis was performed on selected prescrip-
tion data including rosiglitazone, atorvastatin, simvas-
tatin, sertraline, paroxetine, risperidone, and olanzapine.
Prior to implementation, only 65% (3918/6000) of eligi-
ble prescriptions were tablet split. Within 6 months, the
rate increased to 80% (5357/6680) with an estimated
annual cost savings of US$158,000.00. Rate increased
10–92% per medication. CONCLUSIONS: Incorporat-
ing a tablet splitting guide with physician order entry is
an efﬁcient method of realizing substantial cost savings.
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OBJECTIVES: Quantifying the impact of falling on
health care utilization and costs is important for under-
standing the economic consequences of this problem, and
for gauging the potential beneﬁts from falls prevention
programs. METHODS: The study examines a unique
falls database of older, community-dwelling individuals.
We examine costs for emergency room care, hospitaliza-
tion. Home health care, and long-term care. We also
investigate total costs, using both two-part models and
propensity scoring methods. The two-part model is a tra-
ditional approach to estimating costs when costs depend
on the decision to use care as well as on costs conditional
on use. The propensity scoring approach provides a non-
parametric alternative. RESULTS: Relative to nonfallers,
individuals incurring a single fall have total annual costs
that are $4484 to $8177 higher. The larger estimate 
was obtained using propensity scoring techniques. For
multiple fallers, total costs increase from $7,422 (2-part
method) to $13,045 (propensity scoring method). These
differences are highly signiﬁcant (p < 0.01). Falling 
signiﬁcantly increases each type of health care cost 
examined, and the estimated effects are greater using the
propensity score approach. For single fallers, emergency
room costs increase by $106 to $119 annually; hospital
costs by $2787 to $4856; home health care costs by 
$153 to $291; and long term care costs by $1,710 
to $2913. For multiple fallers, emergency room costs
increase by $123 to $158; hospital costs by $3916 to
$4510; home health care costs by $371 to $755; and long
term care costs by $2541 to $7621. These patterns pri-
marily reﬂect a greater tendency to utilize care rather than
a greater intensity of treatment among users of care.
CONCLUSIONS: Falling raises health care costs sub-
stantially. The results using propensity scoring methods
suggest that the magnitude of these effects may be sub-
stantially greater than suggested by previous research that
used traditional parametric approaches.
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THE COST-EFFECTIVENESS OF OSTEOGENIC
PROTEIN 1 IN THE TREATMENT OF TIBIAL
NONUNIONS IN THE UK AND GERMANY
van Engen AK,Vinken AG
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OBJECTIVES: In this study, a decision model analysis
was performed, comparing the overall clinical efﬁcacy
and total costs in the treatment of tibial nonunions in the
UK and in Germany. In the UK treatment with osteogenic
protein 1 (OP-1) was compared to autograft or the
Ilizarov ﬁxation technique, and in Germany treatment
with OP-1 was compared to ﬁxation with a nail or a plate
and if appropriate autograft. METHODS: The analysis
was based on a decision tree. Data on efﬁcacy were
obtained from clinical trials and literature. Medical
resource use data were obtained from country-speciﬁc
expert panels. UK and German hospital direct medical
costs of treatment were determined using standard
costing techniques. The primary end-point was the total
average cost of treatment of tibial nonunions. Univariate
sensitivity analyses were performed to test the robustness
of the model. RESULTS: In the UK, total cost per average
patient receiving OP-1 treatment were £8797 compared
to £9084 for autograft and £9722 for the Ilizarov ﬁxa-
tion technique. The cost effectiveness ratio, cost per
patient with a healed fracture, was comparable between
the 3 treatment options; £10,860 for OP-1 treatment,
£10,687 for autograft treatment and £10,234 for the
Ilizarov ﬁxation technique. In Germany, total cost per
average patient receiving OP-1 treatment were €15,156
compared to €14,348 for usual care. The cost effective-
ness ratio, cost per patient with a healed fracture, was
better for usual care than for OP-1, but only slightly so.
CONCLUSIONS: This study indicates that OP-1 is a
good alternative treatment for tibial nonunions, both
from a clinical and an economic perspective. Parameters
inﬂuencing cost-effectiveness included % of adverse
events and number of days in hospital. Prospective data
is needed to conﬁrm these results.
